VICTOR: Vericiguat Did Not Meet Primary Endpoint But Reduced CV Death in Stable, Ambulatory HFrEF
Key Points: The VICOTRIA trial previously demonstrated that vericiguat reduced the risk…
VICTOR + VICTORIA: Vericiguat Showed Benefits Across the Spectrum of HFrEF Severity
Key Points: VICTORIA and VICTOR and were randomized trials that evaluated vericiguat…
ABC-AF Trial: Personalized Risk-Based Treatment Did Not Improve Outcomes in Patients with Atrial Fibrillation
Key Points: The ABC-AF trial evaluated whether treatment recommendations based on biomarker-based…
BaxHTN: Baxdrostat Significantly Reduced Blood Pressure in Patients with Uncontrolled or Resistant Hypertension
Key Points: Uncontrolled and resistant hypertension remains a major challenge despite treatment…
HI-PRO Trial: Extended Low-Intensity Apixaban Reduces Recurrent VTE in Patients with Provoked VTE and Enduring Risk Factors
Key Points: Standard anticoagulation for provoked venous thromboembolism (VTE) is often discontinued…
MAPLE-HCM: Aficamten Superior to Metoprolol for Improving Exercise Capacity in Symptomatic Obstructive HCM
Key Points: Beta-blockers are widely used as first-line therapy for obstructive hypertrophic…
An Invasive vs Conservative Strategy Safe But Does Improve MACE in Frail Older NSTEMI Patients: SENIOR-RITA Frail
Key Points: Evidence for NSTEMI management among older adults is limited, and…
LOSE-AF: Weight Loss Alone Does Not Improve AF Symptoms or Burden in Older Adults
Key Points: LOSE-AF is the first randomized trial to rigorously assess the…
Clopidogrel Monotherapy Significantly Reduced MACE vs Aspirin Monotherapy Post-PCI: SMART-CHOICE 3
Key Points: Standard cardiology practice recommends aspirin monotherapy indefinitely after DAPT for…
FFR-Guided PCI Associated with Higher Rates of MI Compared to CABG in MVD: Five-Year Results from FAME-3
Key Points: The FAME 3 trial tested whether percutaneous coronary intervention (PCI)…
Sudden Cardiac Arrest Survival Worse in Minorities Among Young Athletes: RACER Cohort from 2010–2023
Key Points: This study presents updated national data from the Race Associated…
Altshock2: No Benefit to IABP in HF-Cardiogenic Shock
Key Points: Prior trials have demonstrated limited benefit to intra-aortic balloon pump…
No Benefit to Fluid Restriction in Chronic HF: FRESH UP
Key Points: While fluid restriction is a standard recommendation for patients with…
Biomarkers Show Limited Utility in Guiding Early TAVR Timing for Asymptomatic Severe AS: EARLY TAVR Trial
Key Takeaways: Elevated baseline NT-proBNP and hs-cTnT levels were associated with higher…
Autologous Bone Marrow Cell Therapy Failed to Meet Primary Endpoint in Ischemic Heart Failure: CardiAMP-HF
Key Takeaways: Intramyocardial autologous bone marrow cell therapy was safe in patients…
SHR-1918 Safe, Significantly Lowered LDL-C and Triglycerides in Poorly Controlled Hyperlipidemia
Key Takeaways: SHR-1918, an ANGPTL3 inhibitor, significantly reduced LDL cholesterol by approximately…
AI-Based ECG Model Enhances Detection of Heart Attack and Need for Coronary Revascularization
Key Takeaways: A deep learning ECG model significantly outperforms clinician interpretation in…
AI Accurately Detected Severe AS on TTE but Uptake Low Amongst Clinicians: Insights from a Randomized Crossover Study
Key Points: In a randomized crossover study, authors assessed whether artificial intelligence…
PRAGUE-25: Lifestyle Modification Plus Antiarrhythmic Drugs Inferior to Catheter Ablation In Obese Patients
Key Points: Obesity increases the risk of atrial fibrillation (AF) by 19–29%…
ZENITH Trial: Sotatercept Significantly Reduces Major Morbidity and Mortality Events in High-Risk PAH Patients
Key Points: Pulmonary arterial hypertension (PAH) is a progressive disease with poor…